In 2019,Latin American Journal of Pharmacy included an article by Dong, Hui; Weng, Yibing; Zhen, Genshen. Category: alcohols-buliding-blocks. The article was titled 《Clinical efficacy of atomizing inhalation of ambroxol hydrochloride in treatment of chronic bronchitis in elderly patients》. The information in the text is summarized as follows:
This study aimed to investigate the clin. efficacy of atomizing inhalation of ambroxol hydrochloride in treatment of chronic bronchitis in elderly patients. Four hundred elderly patients with chronic bronchitis were randomly divided into control and observation group, which received conventional treatment and atomizing inhalation of ambroxol hydrochloride based on conventional treatment, resp. After treatment, compared with control group, in observation group the disappearance time of clin. symptoms was decreased (P < 0.05), the total effective rate was increased (P < 0.01), the lung function, life quality and daily activity ability were improved (P < 0.05), the serum IL-2 level was increased (P < 0.05), and the serum IL-6 and TNF-α levels were decreased (P < 0.05). There was no significant difference of adverse reaction between two groups (P > 0.05). Atomizing inhalation of ambroxol hydrochloride can quickly and effectively alleviate the clin. symptoms of chronic bronchitis in elderly patients. The experimental part of the paper was very detailed, including the reaction process of trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol hydrochloride(cas: 23828-92-4Category: alcohols-buliding-blocks)
trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol hydrochloride(cas: 23828-92-4) is a medication indicated to alleviate chest congestion associated with conditions that include bronchitis, pneumonia, bronchospasm asthma, cough, and allergy.Category: alcohols-buliding-blocks Preclinically, ambroxol, the active ingredient of Mucosolvan, has been shown to increase respiratory tract secretion.
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts